Previous Section | Index | Home Page |
Mr. Burstow: To ask the Secretary of State for Health (1) if he will set out the timetable for commencement of section 49 of the Health and Social Care Act 2001 for each group affected by the provision; [4924]
(3) if he will make a statement on the draft guidance and directions he plans to issue to implement the provisions of section 49 of the Health and Social Care Act 2001; [4869]
Jacqui Smith: I refer the hon. Member to the reply I gave my hon. Friend the Member for Stafford (Mr. Kidney) on 17 July 2001, Official Report, columns 11314W.
Mr. Burstow: To ask the Secretary of State for Health, pursuant to his answer of 11 July 2001, Official Report, on anti-psychotic medication, what work his Department has undertaken to explain the trend in prescribing; what were the key findings; and if he will set out prescription numbers (a) by region and (b) by ages (i) under 16, (ii) 16 to 25, (iii) 26 to 35, (iv) 36 to 45, (v) 46 to 55, (vi) 56 to 65, (vii) 66 to 75 and (viii) over 75. [5292]
Jacqui Smith: The National Institute for Clinical Excellence (NICE) is expected to issue guidance on the use of these drugs in December.
19 Jul 2001 : Column: 443W
We do not hold prescribing information on the age breakdown asked for.
Notes:
1. The prescription information is from the Prescription Cost Analysis (PCA) system and is based on a full analysis of all prescriptions dispensed in the community, i.e. by community pharmacists and appliance contractors, dispensing doctors and prescriptions submitted by prescribing doctors for items personally administered in England. Also included are prescriptions written in Wales, Scotland, Northern Ireland and the Isle of Man but dispensed in England. The information shows the number of prescription items dispensed in each health authority. The data do not cover drugs dispensed in hospital or private prescriptions.
2. Atypical anti-psychotics are defined within British National Formulary paragraph 4.2.1, antipsychotic drugs, and cover the drugs Amisulpride, Clozapine, Olanzapine, Quetiapine, Risperidone and Zotepine,
19 Jul 2001 : Column: 444W
(43) Exempt
(44) Charged
(45) Includes prepayments
Notes:
1. The age related information is based on an analysis of those not required to pay a charge indicated by the categories completed on the back of the prescription form. This is based on a 1 in 20 sample of all prescription items submitted to the Prescription Pricing Authority by community pharmacists and appliance contractors only. Dispensing doctor prescriptions were not analysed into categories for 1999 and most of 2000. Personally administered items are free of charge.
2. Atypical anti-psychotics are defined within British National Formulary paragraph 4.2.1, antipsychotic drugs, and cover the drugs Amisulpride, Clozapine, Olanzapine, Quetiapine, Risperidone and Zotepine.
19 Jul 2001 : Column: 445W
Mr. Frank Field: To ask the Secretary of State for Health what proportion of people aged 65 years and over receive community-based services. [5218]
Jacqui Smith: As at 31 March 2000 (the latest date for which data are available), an average of 8.5 per cent. of people in England aged 65 years and over were in receipt of community-based social services provided or commissioned by local authorities.
In 19992000, the latest year for which information is available, it is estimated that 21 per cent. of people aged 65 and over were receiving care from the district nursing service, 2 per cent. from health visitors and 2 per cent. from the community psychiatric nursing service. Contact with the community learning disability service for this age group was negligible. We do not hold data centrally on the proportion of people aged 65 and over who receive primary care-based services.
Mr. Goodman: To ask the Secretary of State for Health how many nursing and residential care (a) homes and (b) beds have closed in Buckingham in each year since 1997. [5637]
Jacqui Smith: The number of residential and nursing care establishment closures in 1999 and 2000, together with number of new registrations, are shown in the table. Information is not available centrally on the number of beds associated with closures or new registrations.
(46) Buckinghamshire county council and Milton Keynes council
(47) Buckinghamshire health authority
(48) Not available
Source:
Registration and Inspection Survey
19 Jul 2001 : Column: 446W
David Maclean: To ask the Secretary of State for Health how many nursing and residential care (a) homes and (b) beds have closed in Cumbria in each year since 1997. [5764]
Jacqui Smith: The number of residential and nursing care establishment closures in 1999 and 2000, together with number of new registrations, are shown in the table. Information is not available centrally on the number of beds associated with closures or new registrations.
1999 | 2000 | ||
---|---|---|---|
Number of establishment closures | |||
Residential(49) | 19 | 11 | |
Nursing(50) | 2 | 2 | |
Number of new registrations | |||
Residential(49) | 15 | 8 | |
Nursing(50) | 0 | 0 |
(49) Cumbria county council
(50) North Cumbria and Morecambe Bay health authorities
Source:
Registration and Inspection Survey
Next Section | Index | Home Page |